Immunotherapy has emerged as a revolutionary approach in the treatment of various malignancies. It leverages the body’s immune system to combat cancer, thereby reducing the adverse effects associated with traditional cancer treatments. This article aims to provide physicians with a comprehensive understanding of the fundamentals of immunotherapy.
Immunotherapy works by enhancing or suppressing the immune system's response. It can be classified into active, passive, and hybrid based on the approach. Active immunotherapy stimulates the immune system to work harder or smarter to attack cancer cells. In contrast, passive immunotherapies essentially provide the immune system with components, such as man-made immune system proteins, to improve the body's response.
Immunotherapy encompasses a wide array of therapeutic strategies. These include monoclonal antibodies that target specific parts of cancer cells, cancer vaccines, and non-specific immunotherapies. Additionally, checkpoint inhibitors that help the immune system recognize and attack cancer cells, and Chimeric Antigen Receptor (CAR) T-cell therapy, which involves altering T cells in the laboratory to attack cancer cells, are significant advances in this field.
Immunotherapy has been approved for the treatment of a variety of cancers, including lung, melanoma, head and neck, bladder, and kidney cancers. The effectiveness of immunotherapy can vary, with some patients experiencing complete remission while others may not respond. Factors influencing responsiveness include the type of cancer, its stage, and the patient's overall health.
Immunotherapy is a promising frontier in cancer treatment. Understanding its principles, types, and applications can equip physicians with the knowledge to make informed decisions about its use in patient care. As research progresses, the potential of immunotherapy continues to grow, underscoring the importance of staying abreast of developments in this rapidly evolving field.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation